Education
About Us
Working with TipRanks
Follow Us
Iovance Biotherapeutics (GB:0JDK)
:0JDK
RESEARCH TOOLSreports
0JDK Analyst Ratings
Moderate Buy
9 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0JDK Stock 12 Month Forecast
Average Price Target
$11.33
▲(475.13%Upside)
| Highest Price Target$25.00 | Average Price Target$11.33 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Goldman Sachs
$16→$8
Buy
306.09%
Upside
Reiterated
06/03/25
Citizens JMP
―
Hold
―
Reiterated
06/03/25
H.C. Wainwright
$20
Buy
915.23%
Upside
Reiterated
06/03/25
TD Cowen
$5
Buy
153.81%
Upside
Reiterated
06/02/25
Barclays
$4
Buy
103.05%
Upside
Reiterated
06/02/25
Wells Fargo
$18
Buy
813.71%
Upside
Reiterated
06/01/25
UBS
$2
Hold
1.52%
Upside
Downgraded
05/16/25
Truist Financial
$5
Hold
153.81%
Upside
Downgraded
05/12/25
Chardan Capital
$30→$25
Buy
1169.04%
Upside
Reiterated
05/09/25
Robert W. Baird
$20→$3
Hold
52.28%
Upside
Downgraded
05/09/25
Mizuho Securities
$30→$10
Buy
407.61%
Upside
Reiterated
05/09/25
Stifel Nicolaus
$18
Buy
813.71%
Upside
Reiterated
03/17/25
Jefferies
$23→$18
Buy
813.71%
Upside
Reiterated
03/13/25
Piper Sandler
$7.5→$6
Hold
204.57%
Upside
Reiterated
02/28/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
$16→$8
Buy
306.09%
Upside
Reiterated
06/03/25
Citizens JMP
―
Hold
―
Reiterated
06/03/25
H.C. Wainwright
$20
Buy
915.23%
Upside
Reiterated
06/03/25
TD Cowen
$5
Buy
153.81%
Upside
Reiterated
06/02/25
Barclays
$4
Buy
103.05%
Upside
Reiterated
06/02/25
Wells Fargo
$18
Buy
813.71%
Upside
Reiterated
06/01/25
UBS
$2
Hold
1.52%
Upside
Downgraded
05/16/25
Truist Financial
$5
Hold
153.81%
Upside
Downgraded
05/12/25
Chardan Capital
$30→$25
Buy
1169.04%
Upside
Reiterated
05/09/25
Robert W. Baird
$20→$3
Hold
52.28%
Upside
Downgraded
05/09/25
Mizuho Securities
$30→$10
Buy
407.61%
Upside
Reiterated
05/09/25
Stifel Nicolaus
$18
Buy
813.71%
Upside
Reiterated
03/17/25
Jefferies
$23→$18
Buy
813.71%
Upside
Reiterated
03/13/25
Piper Sandler
$7.5→$6
Hold
204.57%
Upside
Reiterated
02/28/25
Best Analysts Covering Iovance Biotherapeutics
1 Month
xxx
Success Rate
14/32 ratings generated profit
Average Return
+2.35%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 43.75% of your transactions generating a profit, with an average return of +2.35% per trade.
3 Months
xxx
Success Rate
9/15 ratings generated profit
Average Return
+9.89%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +9.89% per trade.
1 Year
Success Rate
14/32 ratings generated profit
Average Return
+7.83%
reiterated a buy rating last month
Copying Geulah Livshits's trades and holding each position for 1 Year would result in 43.75% of your transactions generating a profit, with an average return of +7.83% per trade.
2 Years
xxx
Success Rate
7/32 ratings generated profit
Average Return
-35.18%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 21.88% of your transactions generating a profit, with an average return of -35.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0JDK Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
16
17
15
16
14
Buy
8
4
3
1
1
Hold
2
2
2
6
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
23
20
23
22
Each month's total comprises the sum of three months' worth of ratings.
0JDK Financial Forecast
0JDK Stock Forecast FAQ
What is GB:0JDK’s average 12-month price target, according to analysts?
Based on analyst ratings, Iovance Biotherapeutics’s 12-month average price target is 11.33.
What is GB:0JDK’s upside potential, based on the analysts’ average price target?
Iovance Biotherapeutics has 475.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Iovance Biotherapeutics a Buy, Sell or Hold?
Iovance Biotherapeutics has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 5 hold ratings and 0 sell ratings.
What is Iovance Biotherapeutics’s share price target?
The average share price target for Iovance Biotherapeutics is 11.33. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $25.00 ,and the lowest forecast is $2.00. The average share price target represents 475.13% Increase from the current price of $1.97.
The highest analyst share price target is $25.00 ,and the lowest forecast is $2.00. The average share price target represents 475.13% Increase from the current price of $1.97.
What do analysts say about Iovance Biotherapeutics?
Iovance Biotherapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Iovance Biotherapeutics?
To buy shares of GB:0JDK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.